Patients with tumor lysis syndrome and evidence of uric acid nephropathy require treatment with rasburicase to reduce serum urate levels.
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p3563